Adcock Ingram Holdings is principally engaged as a manufacturer, marketer and distributor of healthcare products. Co.'s product portfolio includes branded and generic prescription medicines and over the counter/fast moving consumer goods brands, intravenous products, blood collection products and renal dialysis systems. Co. operates within three segments: over the counter, which comprises pharmaceutical products available without prescription as well as personal care products; prescription, which comprises products available on prescription only; and hospital products.
theScreener is the market leader for independent valuations of financial securities, equities, sectors and markets, and new funds. theScreener's ratings, analyses are used by leading banks, asset managers and financial portals. Approximately 10,000 workstations benefit from theScreener's services, with over millions of customer accounts actively analysed.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.